#-supreme-cart-checklist-5-2808{items-data:[{"text":"Term length and renewal options"},{"text":"Service level agreements and response times"},{"text":"Liability and indemnification"},{"text":"Cost structure and billing terms"},{"text":"Termination provisions"},{"text":"Ensuring Regulatory compliance"}]}#-supreme-cart-playbook-navigation-7-2808{topics-data:[{"title":"Patient Selection & Support","description":"Identify,refer,and support eligible patients.","url":"\/playbook\/patient-selection-and-support\/","cta_text":"Explore","accent":"pink"},{"title":" Guidance for CAR T-related adverse reactions ","description":"Patient monitoring,after-hour considerations,admissions and emergency partners ","url":"\/playbook\/guidance-for-car-t-related-adverse-reactions\/","cta_text":"Explore","accent":"pink"},{"title":"Reimbursement,Billing & Coding","description":"Coding,payment mechanics and the questions payers ask before covering CAR-T at a community site.","url":"\/playbook\/reimbursement-and-billing\/","cta_text":"Explore","accent":"pink"}]}#-supreme-cart-staffing-training-4-2808{cards-data:[{"title":"Hub-and-Spoke Model","description":"Your center partners with an established CAR-T program that covers what you do not build,with referral,handoff and follow-up responsibilities agreed in advance."},{"title":"Direct Contracting","description":"You contract directly with product developers and third-party providers. Site qualification with each manufacturer is what gives your center access to the product."},{"title":"Health System Affiliation","description":"You draw on a parent or affiliated health system for inpatient beds,ICU escalation and accreditation infrastructure while treatment stays in the community setting."}]}#-supreme-faq-accordion-3-2808{faqs-data:[{"question":"Apheresis","answer":"Apheresis collection drives product quality and shapes the patient\u2019s first experience of your program. It is also one of the most commonly contracted services,and several qualified providers can step into the need. Contracting collection lets a center move faster and concentrate its own effort on the capabilities that cannot be bought."},{"question":"ICU \/ Emergency Care","answer":"A community center treating patients in the outpatient setting needs a defined route to inpatient and ICU-level care before the first infusion. Published guidance calls for rapid access to emergency services and intensive care units capable of managing severe adverse reactions,and one community practice met this by partnering with a regional hospital. Agreements should name the admitting service,the escalation pathway and expected response times,and extend to ambulance,emergency department,ICU,neurology and cardiology."},{"question":"Pharmacy \/ Drug Handling","answer":"Cell therapy products are patient-specific,arrive frozen and cannot be replaced,so receipt,storage and thaw call for pharmacy capability many community sites have not yet built. Distributors and other third-party providers can take on product handling,cold chain management,inventory management,regulatory compliance and contingency planning. Regulatory compliance,including chain of identity,chain of custody verification,is a shared responsibility so written compliance programs are needed."},{"question":"Distribution & Procurement Channel","answer":"Settle early how the product will be acquired and who carries the cost between purchase and payment. Under buy-and-bill,your center purchases,stores and administers the product and then submits a claim,so you hold both the inventory and the financial exposure. Specialty pharmacy and blended arrangements move some of that elsewhere. Distributors can also take on inventory management,ordering and regulatory compliance. Whichever channel you choose,agree it in writing before the first patient is scheduled."},{"question":"Transport \/ Logistics","answer":"Cell therapy moves on a schedule with little room for error,from collection to the manufacturing site and return. Distributors can carry cold chain management,logistics support,scheduling and coordination,and contingency planning,which removes substantial workload from the treatment center. This is subject to regulation so be sure your partner can assure compliance. Patient transport is a separate arrangement:an outpatient program also needs an agreed route to the hospital,including ambulance service,when a patient requires admission."},{"question":" Payer Contracting & Site of Care","answer":"Coverage is the contracting conversation worth starting earliest. It is possible to secure prior authorization and single-case agreements with commercial payers before apheresis begins. It is worth confirming which of your existing contracts cover cell therapy at your site of care. Agree in advance who prepares single-case agreements and who handles appeals. "}]}